Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation THT 2025

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Presenter: Lucas Zier

February 13, 2025

Presentation THT 2025

Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study

Presenter: Navin Kapur

February 12, 2025

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT 2024

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Presenter: Lucas Zier

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT 2023

The Nephronyx Perfuser: A Novel Device That Targets Increased Renal Venous Pressure in Patient With Cardiorenal Syndrome

Presenter: Oren Caspi

March 21, 2023

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Presentation THT 2022

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

Presenter: Waleed Al-Darzi

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

Advertisement

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Debating the Role of T-TEER in the Sickest Patients

The Nephronyx Perfuser: A Novel Device That Targets Increased Renal Venous Pressure in Patient With Cardiorenal Syndrome

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Utilization of Left-Atrial Venous Arterial Extracorporeal Membrane Oxygenation for Biventricular Failure in Cardiogenic Shock

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content